Peggy L. Porter

ORCID: 0000-0002-8271-401X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Risks and Factors
  • Breast Cancer Treatment Studies
  • BRCA gene mutations in cancer
  • Cancer Genomics and Diagnostics
  • Estrogen and related hormone effects
  • Global Cancer Incidence and Screening
  • Cancer-related Molecular Pathways
  • Genomic variations and chromosomal abnormalities
  • Breast Lesions and Carcinomas
  • PARP inhibition in cancer therapy
  • Gene expression and cancer classification
  • Cancer Cells and Metastasis
  • Cervical Cancer and HPV Research
  • DNA Repair Mechanisms
  • Genetic factors in colorectal cancer
  • HER2/EGFR in Cancer Research
  • RNA modifications and cancer
  • Advanced Breast Cancer Therapies
  • Advanced Proteomics Techniques and Applications
  • Metastasis and carcinoma case studies
  • Male Breast Health Studies
  • Cancer, Lipids, and Metabolism
  • Cancer Research and Treatments
  • Multiple and Secondary Primary Cancers
  • Cancer Immunotherapy and Biomarkers

Fred Hutch Cancer Center
2014-2023

University of Washington
2010-2023

Seattle University
1995-2023

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa
2002-2021

Cancer Research Center
2002-2021

University of Michigan–Ann Arbor
2006-2019

Insight Genetics (United States)
2019

Myriad Genetics
2019

The University of Texas MD Anderson Cancer Center
2019

Yale Cancer Center
2019

Targeted disruption of the murine p27Kip1 gene caused a dose–dependent increase in animal size without other gross morphologic abnormalities. All tissues were enlarged and contained more cells, although endocrine abnormalities not evident. Thymic hyperplasia was associated with increased T lymphocyte proliferation, cells showed enhanced IL-2 responsiveness vitro. Thus, p27 deficiency may cause cell-autonomous defect resulting proliferation response to mitogens. In spleen, absence selectively...

10.1016/s0092-8674(00)81239-8 article EN cc-by-nc-nd Cell 1996-05-01

Abstract BACKGROUND The incidence of anal cancer has increased among both men (160%) and women (78%) from 1973 to 2000 in the U.S. authors conducted a population‐based case–control study examine factors that may account for this increase. METHODS Men ( n = 119 patients) 187 who were diagnosed with between 1986 1998 Seattle area ascertained through local Surveillance, Epidemiology, End Results registry. Control participants 1700) random‐digit telephone dialing. Participants interviewed person...

10.1002/cncr.20365 article EN Cancer 2004-06-02

Background: Among women who practice breast self-examination (BSE), cancers may be detected when they are at an earlier stage and smaller than in do not BSE. However, the efficacy of for decreasing cancer mortality is unproven. This study was conducted to determine whether intensive program BSE instruction will reduce number dying cancer. Methods: From October 1989 through 1991, 266 064 associated with 519 factories Shanghai were randomly assigned a group (132 979 women) or control (133 085...

10.1093/jnci/94.19.1445 article EN JNCI Journal of the National Cancer Institute 2002-10-01

Interview with Peggy Porter on the increased rate of breast cancer in lower-income countries. (07:03)Download Recent media reports have highlighted increasing incidence low- and middle-income Although disease continues to be most prominent affluent countries, risks both death due are clearly worldwide (see maps). Some 45% more than 1 million new cases diagnosed each year, 55% breast-cancer–related deaths, occur countries.1 Such countries now face challenge effectively detecting treating a...

10.1056/nejmp0708307 article EN New England Journal of Medicine 2008-01-16

Abstract Few population‐based case‐control studies have assessed etiologic factors for penile cancer. Past infection with high‐risk human papillomavirus (HPV) is a known risk factor cancer; however, few previous related the HPV DNA status of tumor to potential demographic and behavioral disease or evaluated whether in situ invasive cancer share factors. Little information available on role timing circumcision etiology We conducted study western Washington state that included 137 men...

10.1002/ijc.21009 article EN International Journal of Cancer 2005-04-11

HERE IS CONSIDERABLE EVIdence from observational studies, 1 and now a randomized controlled trial, the Women's Health Initiative (WHI), 2 that use of combined estrogen progestin hormone replacement therapy (CHRT) is associated with an increased risk breast cancer.Specifically, pooled analysis 51 studies found current users CHRT or alone for 5 years longer had 53% increase in cancer, after 5.2 follow-up WHI reported was statistically nonsignificant 26% cancer risk. However, few have evaluated...

10.1001/jama.289.24.3254 article EN JAMA 2003-06-24

Abstract Previous studies have shown that BRCA1-related breast cancers are often high-grade tumors do not express estrogen receptors, HER2, p27Kip1, or cyclin D1, but p53 and E. In addition, the expression of cytokeratin 5/6 (CK5/6), indicating a basal epithelial phenotype, is frequent in cancer. Here, series 247 cancers, we demonstrate CK5/6 was associated with nearly all features cancer also poor prognosis. parsimonious multivariable proportional hazards model, protein levels E, p53,...

10.1158/0008-5472.can-03-2970 article EN Cancer Research 2004-02-01

Abstract Background The characterization of copy number alteration patterns in breast cancer requires high-resolution genome-wide profiling a large panel tumor specimens. To date, most array comparative genomic hybridization studies have used panels relatively size and high Nottingham Prognostic Index (NPI) that are not as representative demographics. Results We performed an oligo-array-based analysis alterations 171 primary tumors small low NPI, which was therefore more Hierarchical...

10.1186/gb-2007-8-10-r215 article EN cc-by Genome biology 2007-10-07

Purpose: This study examines cell surface ROR1 expression in human tumors and normal tissues. is considered a promising target for cancer therapy due to putative tumor-specific expression, multiple groups are developing antibodies and/or chimeric antigen receptor-modified T cells ROR1. On-target, off-tumor toxicity challenge most nonmutated tumor antigens; however, prior studies suggest that absent on tissues.Experimental Design: Our show published lack sensitivity detect endogenous levels...

10.1158/1078-0432.ccr-16-2083 article EN Clinical Cancer Research 2016-11-17

Background: Younger women (40–49 years) have lower mammographic sensitivity (i.e., greater proportion of cancers detected after a negative mammogram) than older (≥50 years). We explored the effect tumor growth rate, breast density, image quality, and cancer risk factors on in younger women. Methods: studied 576 (n = 73 aged 40–49 years n 503 50 or older) who were diagnosed with invasive between 1988 1993. Interval defined as those within 12 24 months screening mammogram before subsequent...

10.1093/jnci/djh269 article EN JNCI Journal of the National Cancer Institute 2004-10-05

BACKGROUND Obesity has been shown to affect breast carcinoma prognosis, with the heaviest women having a higher mortality due carcinoma. Few studies have focused on premenopausal or correlation of body mass index (BMI) tumor characteristics related prognosis. METHODS The authors conducted population-based follow-up study for 1177 younger than 45 years age who had invasive ductal diagnosed from 1983 through 1992. Histologic slides and/or tissue were collected pathologic review,...

10.1002/1097-0142(20010815)92:4<720::aid-cncr1375>3.0.co;2-t article EN Cancer 2001-01-01

BACKGROUND: Although mammographic screening is useful for detecting early breast cancer, some tumors are detected in the interval between examinations. This study attempted to characterize fully two different manners. METHODS: Our utilized a case-control design and involved cohort of women undergoing within defined population health maintenance organization (the Group Health Cooperative Puget Sound). Women were classified as having "interval" or " interval-detected" cancers (n = 150) if...

10.1093/jnci/91.23.2020 article EN JNCI Journal of the National Cancer Institute 1999-12-01

Abstract Little is known about the etiologic profile of triple-negative breast cancer (negative for estrogen receptor/progesterone receptor/human epidermal growth factor), a subtype associated with high mortality and inadequate therapeutic options. We undertook this study to assess risk among women 45 years age younger in relation demographic/lifestyle factors, reproductive history, oral contraceptive use. Study participants were ascertained two previous population-based, case-control...

10.1158/1055-9965.epi-08-1005 article EN Cancer Epidemiology Biomarkers & Prevention 2009-04-01

The efficacy of breast self-examination in helping to reduce mortality from cancer has not been rigorously demonstrated.To assess efficacy, a large, randomized trial was initiated Shanghai, China.From October 1989 1991, 267040 current and retired female employees associated with 520 factories the Shanghai Textile Industry Bureau were randomly assigned on basis factory either instruction group (133375 women) or control (133665 women). women born within period 1925 through 1958. Women given...

10.1093/jnci/89.5.355 article EN JNCI Journal of the National Cancer Institute 1997-03-05

Abstract In this study, we performed high-resolution array comparative genomic hybridization with an of 4153 bacterial artificial chromosome clones to assess copy number changes in 44 archival breast cancers. The tumors were flow sorted exclude non-tumor DNA and increase our ability detect gene changes. these tumors, losses more frequent than gains, gains 1q loss 16q the most alterations. We compared based on histologic subtype estrogen receptor (ER) status, i.e., ER-negative infiltrating...

10.1158/0008-5472.can-04-1992 article EN Cancer Research 2004-12-01

SPARC (Secreted Protein, Acidic and Rich in Cysteine)/osteonectin is a secreted glycoprotein that exhibits restricted expression murine adult embryonic tissues associated with cell migration, matrix mineralization, steroid hormone production, cycle regulation, angiogenesis. We produced monoclonal antibody, MAb SSP2, against Ca(2+)-binding region of evaluated the immunoreactivity normal malignant tissue from 118 human samples. In we found moderate reactivity SSP2 steroidogenic cells,...

10.1177/43.8.7622842 article EN Journal of Histochemistry & Cytochemistry 1995-08-01
Coming Soon ...